Loading clinical trials...
Loading clinical trials...
The Treatment of Menstrually-Related Mood Disorders With Extended Versus Interrupted Oral Contraceptives
Conditions
Interventions
Ethinyl Estradiol/Drospirenone
Placebo
+1 more
Locations
1
United States
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States
Start Date
July 1, 2004
Primary Completion Date
June 1, 2010
Completion Date
June 1, 2010
Last Updated
August 25, 2017
NCT07225504
NCT06724419
NCT06704594
NCT06648382
NCT07013539
NCT07461051
Lead Sponsor
National Institute of Mental Health (NIMH)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions